glioma
Showing 26 - 50 of 1,926
Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)
Not yet recruiting
- Recurrent High Grade Glioma
- +4 more
- PCI 24781
- Temozolomide
- (no location specified)
Jan 24, 2023
Recurrent High Grade Glioma Trial (MVR-C5252)
Not yet recruiting
- Recurrent High Grade Glioma
- MVR-C5252
- (no location specified)
Nov 6, 2023
MRI-based Computer Aided Diagnosis Software (V1) for Glioma
Enrolling by invitation
- Glioma
- Primary Brain Tumor
-
Shanghai, Shanghai, ChinaZhen Fan
Feb 11, 2023
Gliomas Using Radiomic Analysis
Not yet recruiting
- Glioma
- Radiomic analysis of imaging - MRI, PET, CT
- (no location specified)
Sep 6, 2023
Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)
Not yet recruiting
- Glioblastoma Multiforme
- +4 more
- SIACI of cetuximab and bevacizumab
-
Miami, FloridaJackson Memorial Hospital
Jul 14, 2023
Motor Cortex; Lesion, Glioma, Supplementary Motor Area Syndrome Trial in Beijing (TMS stimulation treatment, TMS stimulation
Not yet recruiting
- Motor Cortex; Lesion
- +2 more
- TMS stimulation treatment
- TMS stimulation sham-treatment
-
Beijing, Beijing, ChinaBeijing Neurosurgical Institute and Beijing Tiantan Hospital
Mar 25, 2023
Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)
Recruiting
- Oncolytic Virus
- +2 more
- Ad-TD-nsIL12
-
Beijing, Beijing, ChinaSanbo Brain Hospital, Capital Medical University
Jan 29, 2023
Oncolytic Virus, Diffuse Intrinsic Pontine Glioma, Adverse Drug Event Trial in Beijing (Ad-TD-nsIL12)
Recruiting
- Oncolytic Virus
- +2 more
- Ad-TD-nsIL12
-
Beijing, Beijing, ChinaSanbo Brain Hospital, Capital Medical University
Jan 29, 2023
Glioma Trial in Suzhou (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Glioma
- Tumor Infiltrating Lymphocytes (TIL)
-
Suzhou, Jiangsu, ChinaThe Second Affiliated Hospital of Soochow University
Dec 19, 2022
Glioma Trial run by the National Cancer Institute (NCI) (pre-operative abemaciclib, Device for Cerebral Fluid Dialysate
Recruiting
- Glioma
- pre-operative abemaciclib
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Targeted Pediatric High-Grade Glioma Therapy
Not yet recruiting
- High Grade Glioma
- +8 more
-
Aurora, Colorado
- +17 more
May 1, 2023
Optic Pathway Glioma Trial in Rome (CHF6467, Placebo)
Not yet recruiting
- Optic Pathway Glioma
- CHF6467
- Placebo
-
Rome, ItalyCatholic University, Policlinico A. Gemelli (Hospital)
Feb 17, 2023
Glioma, Circulating Tumor Cell Trial in Sabadell (Liquid Biopsy)
Recruiting
- Glioma
- Circulating Tumor Cell
- Liquid Biopsy
-
Sabadell, Barcelona, SpainHospital Universitari Parc TaulĂ
Jul 19, 2023
Glioblastoma, Glioma, Malignant Trial in Rome (Biological sample collection, Dissecting ciliogenesis players, Validating
Recruiting
- Glioblastoma
- Glioma, Malignant
- Biological sample collection
- +2 more
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Mar 6, 2023
Low Grade Glioma Trial in Heidelberg (model-guided optimization of treatment plan, standard treatment plan, no optimization)
Not yet recruiting
- Low Grade Glioma
- model-guided optimization of treatment plan
- standard treatment plan, no optimization
-
Heidelberg, GermanyDepartment of Radiotherapy, University of Heidelberg
Jul 19, 2023
Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San
Recruiting
- Recurrent World Health Organization (WHO) Grade II Glioma
- +3 more
- Hyperpolarized Carbon C 13 Pyruvate
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 21, 2022
Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after
Active, not recruiting
- Oligodendroglioma
- +5 more
- GBM6-AD and poly-ICLC before and after surgery
- GBM6-AD and poly-ICLC after surgery only
-
San Francisco, CaliforniaUniversity of California
Sep 20, 2022
High Grade Glioma Trial (177Lu-PSMA I&T)
Not yet recruiting
- High Grade Glioma
- 177Lu-PSMA I&T
- (no location specified)
Dec 1, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York (Etoposide; Oral, 50 Mg, Focused
Recruiting
- Diffuse Intrinsic Pontine Glioma
- Diffuse Midline Glioma, H3 K27M-Mutant
- Etoposide; Oral, 50 Mg
- Focused ultrasound with neuro-navigator-controlled sonication
-
New York, New YorkColumbia University Irving Medical Center
Feb 28, 2023
Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)
Recruiting
- Low-Grade Glioma
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 24, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma, IDH-Wildtype
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
May 13, 2023
Glioma, Malignant, Computer-Assisted Surgery Trial in Shanghai
Active, not recruiting
- Glioma, Malignant
- Computer-Assisted Surgery
-
Shanghai, Shanghai, ChinaFudan University
Dec 16, 2022